Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features

被引:44
|
作者
Peng, Hong [1 ,2 ]
Huo, Jiaohua [3 ]
Li, Bo [4 ]
Cui, Yuanyuan [1 ,2 ]
Zhang, Hao [1 ,2 ]
Zhang, Liang [3 ]
Ma, Lin [1 ,2 ]
机构
[1] Med Sch Chinese PLA, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Radiol, 28 Fuxing Rd, Beijing 100853, Peoples R China
[3] Xidian Univ, Sch Comp Sci & Engn, Xian 710065, Shaanxi, Peoples R China
[4] Xiangtan Cent Hosp, Dept Radiol, Xiangtan, Peoples R China
关键词
multiparametric MRI; glioma; IDH; support vector machine; GRADE; CLASSIFICATION; SURVIVAL; SYSTEM;
D O I
10.1002/jmri.27434
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging. Purpose To establish a model for classifying IDH status in gliomas based on multiparametric MRI. Study Type Retrospective, radiomics. Population In all, 105 consecutive cases of grade II-IV glioma with 50 IDH1 or IDH2 mutant (IDHm) and 55 IDH wildtype (IDHw) were separated into a training cohort (n = 73) and a test cohort (n = 32). Field Strength/Sequence Contrast-enhanced T-1-weighted (CE-T1W), T-2-weighted (T2W), and arterial spin labeling (ASL) images were acquired at 3.0T. Assessment Two doctors manually labeled the volume of interest (VOI) on CE-T1W, then T2W and ASL were coregistered to CE-T1W. A total of 851 radiomics features were extracted on each VOI of three sequences. From the training cohort, all radiomics features with age and gender were processed by the Mann-Whitney U-test, Pearson test, and least absolute shrinkage and selection operator to obtain optimal feature groups to train support vector machine models. The accuracy and area under curve (AUC) of all models for classifying the IDH status were calculated on the test cohort. Two subtasks were performed to verify the efficiency of texture features and the Pearson test in IDH status classification, respectively. Statistical Tests The permutation test with Bonferroni correction; chi-square test. Results The accuracy and AUC of the classifier, which combines the features of all three sequences, achieved 0.823 and 0.770 (P < 0.05), respectively. The best model established by texture features only had an AUC of 0.819 and an accuracy of 0.761. The best model established without the Pearson test got an AUC of 0.747 and an accuracy of 0.719. Data Conclusion IDH genotypes of glioma can be identified by radiomics features from multiparameter MRI. The Pearson test improved the performance of the IDH classification models. Level of Evidence 4 Technical Efficacy Stage 1
引用
收藏
页码:1399 / 1407
页数:9
相关论文
共 50 条
  • [21] Predicting IDH mutation status of lower grade gliomas using standard MR imaging features and apparent diffusion coefficient
    Shuangshuang Song
    Jiankun Xu
    Leiming Wang
    Fan Yu
    Yueshan Piao
    Miao Zhang
    Jie Lu
    Chinese Journal of Academic Radiology, 2021, 4 : 178 - 185
  • [22] MRI features predict tumor grade in isocitrate dehydrogenase (IDH)–mutant astrocytoma and oligodendroglioma
    David A. Joyner
    John Garrett
    Prem P. Batchala
    Bharath Rama
    Joshua R. Ravicz
    James T. Patrie
    Maria-B. Lopes
    Camilo E. Fadul
    David Schiff
    Rajan Jain
    Sohil H. Patel
    Neuroradiology, 2023, 65 : 121 - 129
  • [23] MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma
    Joyner, David A.
    Garrett, John
    Batchala, Prem P.
    Rama, Bharath
    Ravicz, Joshua R.
    Patrie, James T.
    Lopes, Maria-B
    Fadul, Camilo E.
    Schiff, David
    Jain, Rajan
    Patel, Sohil H.
    NEURORADIOLOGY, 2023, 65 (01) : 121 - 129
  • [24] FUNCTIONAL CHARACTERISATION OF THE ISOCITRATE DEHYDROGENASE 1 (IDH 1) R132H MUTATION IN GLIOMAS
    Biedermann, J.
    Abou El-Ardat, K.
    Conde, M.
    Wiedemuth, R.
    Peitzsch, M.
    Eisenhofer, G.
    Kunz-Schughart, L.
    Temme, A.
    Schroeck, E.
    Klink, B.
    NEURO-ONCOLOGY, 2014, 16
  • [25] Advanced multiparametric MRI-based scoring for isocitrate dehydrogenase mutation prediction of gliomas
    Hosur, Bharat
    Ahuja, Chirag Kamal
    Singla, Navneet
    Gupta, Kirti
    Singh, Paramjeet
    POLISH JOURNAL OF RADIOLOGY, 2022, 87 : E626 - E634
  • [26] Prediction of TERT mutation status in gliomas using conventional MRI radiogenomic features
    Tang, Chuyun
    Chen, Ling
    Xu, Yifan
    Huang, Lixuan
    Zeng, Zisan
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [27] Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
    Zhang, Biqi
    Chang, Ken
    Ramkissoon, Shakti
    Tanguturi, Shyam
    Bi, Wenya Linda
    Reardon, David A.
    Ligon, Keith L.
    Alexander, Brian M.
    Wen, Patrick Y.
    Huang, Raymond Y.
    NEURO-ONCOLOGY, 2017, 19 (01) : 109 - 117
  • [28] PREDICTING ISOCITRATE DEHYDROGENASE GENOTYPE IN MALIGNANT GLIOMA USING FET PET RADIOMICS
    Lohmann, P.
    Lerche, C.
    Bauer, E.
    Steger, J.
    Stoffels, G.
    Filss, C. P.
    Stegmayr, C.
    Neumaier, B.
    Shah, N. J.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2017, 19 : 88 - 89
  • [29] MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting
    Sakai, Yu
    Yang, Chen
    Kihira, Shingo
    Tsankova, Nadejda
    Khan, Fahad
    Hormigo, Adilia
    Lai, Albert
    Cloughesy, Timothy
    Nael, Kambiz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 27
  • [30] Rapid determination of isocitrate dehydrogenase mutation status of human gliomas by extraction nanoelectrospray using a miniature mass spectrometer
    Pu, Fan
    Alfaro, Clint M.
    Pirro, Valentina
    Xie, Zhuoer
    Ouyang, Zheng
    Cooks, R. Graham
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2019, 411 (08) : 1503 - 1508